Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 14,600 shares, a growth of 16.8% from the October 15th total of 12,500 shares. Based on an average trading volume of 18,200 shares, the short-interest ratio is currently 0.8 days.
Arch Therapeutics Trading Up 3.6 %
Shares of OTCMKTS ARTH opened at $0.26 on Friday. The business’s 50 day moving average price is $0.41 and its 200 day moving average price is $0.73. Arch Therapeutics has a 52 week low of $0.17 and a 52 week high of $18.00.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last issued its earnings results on Monday, August 19th. The biotechnology company reported ($1.44) EPS for the quarter. The company had revenue of $0.03 million during the quarter.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Featured Articles
- Five stocks we like better than Arch Therapeutics
- The Basics of Support and Resistance
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Why Invest in 5G? How to Invest in 5G Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Are Dividend Champions? How to Invest in the Champions
- Time to Load Up on Home Builders?
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
